Forsta Ap Fonden Bio Rad Laboratories, Inc. Transaction History

Forsta Ap Fonden

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$463.67 - $597.16 $2.09 Million - $2.69 Million	4,500 New	4,500 $2.23 Million
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $2.41 Million - $2.7 Million	-3,400 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $2.24 Million - $2.81 Million	3,400 New	3,400 $2.54 Million
Q1 2021 May 11, 2021	SELL	$547.01 - $662.35 $1.42 Million - $1.72 Million	-2,600 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$510.68 - $643.45 $1.33 Million - $1.67 Million	2,600 New	2,600 $1.52 Million
Q3 2020 Oct 22, 2020	SELL	$454.43 - $535.6 $1.32 Million - $1.55 Million	-2,900 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $770,201 - $1.13 Million	2,300 Added 383.33%	2,900 $1.31 Million
Q1 2020 May 04, 2020	BUY	$320.01 - $409.07 $192,006 - $245,442	600 New	600 $210,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Forsta Ap Fonden with notifications on news.